Convalescent Plasma Randomized Clinical Trials for SARS-CoV-2 Prophylaxis and Early COVID-19 Treatment are Foundational for Subsequent Hyperimmune Globulin and Vaccines


Total Award Amount

  • 2797913.00
  • Direct Costs

  • 1888373.00
  • Sponsor Award Id

  • Contributor

  • Marisa Marques   Investigator  
  • Paul Goepfert M.D.   Investigator  
  • Randall Davis M.D.   Investigator  
  • Sonya Heath   Principal Investigator  
  • Todd McCarty   Investigator